XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
-0.04 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
3.15
-1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

XBiotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 4.01M 18.39M
Cost of Revenue
n/a 1.74M 651K 5.82M
Gross Profit
n/a -1.74M 3.36M 12.57M
Operating Income
-42.47M -37.51M -34.49M -25.08M
Interest Income
9.81M 10.42M 3.82M 467K
Pretax Income
-38.56M -24.31M -33.59M -25.46M
Net Income
-38.53M -24.56M -32.9M -17.41M
Selling & General & Admin
4.71M 4.66M 6.3M 9.39M
Research & Development
37.76M 32.85M 31.54M 28.27M
Other Expenses
n/a n/a -121K -132K
Operating Expenses
42.47M 37.51M 37.85M 37.66M
Interest Expense
807K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
42.47M 37.51M 38.5M 43.48M
Income Tax Expense
-32K 244K -688K -8.04M
Shares Outstanding (Basic)
30.46M 30.32M 30.44M 30.04M
Shares Outstanding (Diluted)
30.46M 30.44M 30.44M 30.04M
EPS (Basic)
-1.26 -0.81 -1.08 -0.58
EPS (Diluted)
-1.26 -0.81 -1.08 -0.58
EBITDA
-36.01M -35.77M -31.88M -22.43M
EBIT
-39.37M -37.51M -34.49M -25.08M
Depreciation & Amortization
1.75M 1.74M 2.61M 2.65M